Materia Medica Holding, NPF
Company
Pharmaceuticals, Medicine, Healthcare
Since 1992
Russia
Central Federal District of the Russian Federation
Moscow
129272, st. Trifonovskaya, d. 47, p. 1
Since 1992
Russia
Central Federal District of the Russian Federation
Moscow
129272, st. Trifonovskaya, d. 47, p. 1
Since 1992, Materia Medica Holding has been developing and introducing innovative drugs for the treatment of various diseases.
As of November 2019, more than 20 drugs of various therapeutic areas with a high evidence base are presented in Russia, as well as abroad, including the most famous: Ergoferon, Anaferon, Rengalin, Tenoten, Divaza, Afalaza, Impaza, Subetta and others.